Literature DB >> 3761519

Improved cognition after control of risk factors for multi-infarct dementia.

J S Meyer, B W Judd, T Tawaklna, R L Rogers, K F Mortel.   

Abstract

A cohort of 52 patients (30 men and 22 women) with multi-infarct dementia (MID) has been followed up prospectively for a mean interval of 22.2 months. Clinical course has been documented by serial history taking and interviews and neurological, medical, and psychological examinations, and correlated with measurements of cerebral blood flow. The clinical course and cognitive performance have been compared with those of age-matched normal volunteers and patients with Alzheimer's disease. Patients with MID were subdivided into hypertensive and normotensive groups, and also into those displaying stabilized or improved cognition and those whose condition deteriorated. Among hypertensive patients with MID, improved cognition and clinical course correlated with control of systolic blood pressure within upper limits of normal (135 to 150 mm Hg), but if systolic blood pressure was reduced below this level, patients with MID deteriorated. Among normotensive patients with MID, improved cognition was associated with cessation of smoking cigarettes.

Entities:  

Mesh:

Year:  1986        PMID: 3761519

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  22 in total

Review 1.  [Arterial hypertension and dementia].

Authors:  R Scheid; H Voigt
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

Review 2.  Medicine in the elderly.

Authors:  P Diggory; A Homer; J Liddle; C F Pratt; S Samadian; R Tozer; C Weinstein
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

Review 3.  Vascular cognitive impairment: disease mechanisms and therapeutic implications.

Authors:  Deborah A Levine; Kenneth M Langa
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 4.  Are cognitive function and blood pressure related?

Authors:  M Viitanen; Z Guo
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

5.  Diagnosing and treating dementia.

Authors:  R Ramsay; C L Katona
Journal:  BMJ       Date:  1989-01-07

6.  Diagnosing and treating dementia.

Authors:  A M Clarfield
Journal:  BMJ       Date:  1989-03-04

Review 7.  The pharmacoeconomics of dementia therapies. Bringing the clinical, research and economic perspectives together.

Authors:  F J Molnar; W B Dalziel
Journal:  Drugs Aging       Date:  1997-03       Impact factor: 3.923

8.  Psychiatric symptoms in dementia associated with stroke: a case-control analysis among predominantly African-American patients.

Authors:  Y Harris; P B Gorelick; D Cohen; W Dollear; H Forman; S Freels
Journal:  J Natl Med Assoc       Date:  1994-09       Impact factor: 1.798

Review 9.  [Alzheimer Disease].

Authors:  Fadi Massoud
Journal:  Can Fam Physician       Date:  2007-01       Impact factor: 3.275

Review 10.  Hypertension and dementia.

Authors:  Olivier Hanon; Marie Laure Seux; Hermine Lenoir; Anne Sophie Rigaud; Françoise Forette
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.